POPULATION PHARMACOKINETICS OF MAGROLIMAB (5F9, HU5F9--G4) IN PATIENTS WITH SOLID TUMORS AND LYMPHOMAS.

Agoram, B; Jin, C; Wang, B; Sikic, B; Advani, R; Chao, M; Takimoto, C

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020; 107 (): S85